Image-guided liver biopsies are generally safe procedures, but certain risk factors have been identified.
Image-guided liver biopsies can be performed safely, although adverse events can occur among patients with low platelet counts, according to a study published in Mayo Clinic Proceedings.
Researchers from the Mayo Clinic in Rochester, MN, performed a retrospective study to determine the incidence of major adverse events related to a large volume of image-guided liver biopsies performed at their institution over a 12-year period, and to identify risk factors for major bleeding events.
The researchers analyzed 6,613 image-guided liver biopsies that were performed among 5,987 adult patients between December 7, 2001, and December 31, 2013. They were searching for major adverse events, defined as hematoma, infection, pneumothorax, and death.
The biopsies were mostly performed using real-time US guidance.
The results showed that 49 biopsies (0.7%) resulted in acute or major adverse events.
A total of 38 patients experienced 46 major adverse events that presented within 24 hours of the biopsy. “More than two biopsy passes, platelets 50,000/μL or less, and female sex were statistically significant risk factors for postbiopsy hemorrhage,” the authors wrote.
“With appreciation of specific risk factors, safety outcomes of this procedure can be optimized in both general and specialized centers,” the authors concluded.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.